ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

AUTL Autolus Therapeutics PLC

4.50
-0.03 (-0.66%)
Fuera de horario
Última actualización: 15:00:05
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Autolus Therapeutics PLC AUTL NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.03 -0.66% 4.50 15:00:05
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.49 4.32 4.55 4.50 4.53
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/6/202406:00GLOBEAutolus Therapeutics to Present Three Clinical Data Updates..
05/6/202415:35EDGAR2Form 8-K - Current report
03/6/202416:15EDGAR2Form 8-K - Current report
31/5/202407:00GLOBEAutolus Therapeutics presents longer-term follow-up and..
17/5/202415:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/5/202407:27EDGAR2Form 8-K - Current report
17/5/202406:00GLOBEAutolus Therapeutics Reports First Quarter 2024 Financial..
14/5/202409:00GLOBEAutolus Therapeutics to Present Three Clinical Data Updates..
13/5/202408:33EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
13/5/202406:23EDGAR2Form 8-K - Current report
13/5/202406:00GLOBEAutolus Therapeutics Announces Delay to its First Quarter..
24/4/202409:00GLOBEAbstract for longer-term follow-up and additional data..
23/4/202406:00GLOBEAutolus Therapeutics to Report First Quarter 2024 Financial..
02/4/202406:00GLOBEAutolus Therapeutics announces acceptance of Marketing..
01/4/202406:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
14/3/202406:00GLOBEAutolus Therapeutics Reports Full Year 2023 Financial..
12/3/202406:00GLOBEAutolus Therapeutics receives Medicines and Healthcare..
11/3/202406:00GLOBEAutolus Therapeutics announces publication in Blood Cancer..
29/2/202406:00GLOBEAutolus Therapeutics to Report Full Year 2023 Financial..
23/2/202416:28EDGAR2Form D - Notice of Exempt Offering of Securities
22/2/202406:00GLOBEAutolus Therapeutics announces publication in Nature..
21/2/202416:01EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14/2/202407:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202416:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202415:17EDGAR2Form 8-K - Current report
08/2/202406:00GLOBEAutolus Announces Pricing of Underwritten Offering
08/2/202405:06EDGAR2Form 8-K - Current report
08/2/202404:45GLOBEBioNTech and Autolus Announce Strategic CAR-T Cell Therapy..
07/2/202421:00EDGAR2Form S-3ASR - Automatic shelf registration statement of..
31/1/202415:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202412:02EDGAR2Form 8-K - Current report
23/1/202406:00GLOBEAutolus Therapeutics announces publication in ACS Chemical..
22/1/202406:54DJNAutolus Therapeutics Gets BLA Acceptance for Obecabtagene..
22/1/202406:00GLOBEAutolus Therapeutics announces acceptance of Biologics..
10/1/202414:12EDGAR2Form 8-K - Current report
10/1/202406:00GLOBEAutolus Therapeutics announces the appointment of Robert W...
22/12/202307:24EDGAR2Form 8-K - Current report
22/12/202306:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
11/12/202307:31EDGAR2Form 8-K - Current report
09/12/202319:30GLOBEAutolus Therapeutics Presents Clinical Data Updates at the..
28/11/202313:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
27/11/202306:54DJNAutolus Seeks FDA OK of Obe-Cel in Adult B-Cell Acute..
27/11/202306:07EDGAR2Form 8-K - Current report
27/11/202306:00GLOBEAutolus Therapeutics Submits Biologics License Application..
15/11/202306:00GLOBEAutolus Therapeutics to Host Analyst / Investor event at the..
09/11/202315:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:18EDGAR2Form 8-K - Current report
06/11/202306:00GLOBEAutolus Therapeutics announces participation in upcoming..
03/11/202315:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/11/202315:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

Delayed Upgrade Clock